stockrowChina Pharma Holdings, Inc. (CPHI) vs TherapeuticsMD, Inc. (TXMD)
- China Pharma Holdings, Inc. CPHI 0.56 +5.66%
- TherapeuticsMD, Inc. TXMD 1.70 −0.58%
China Pharma Holdings, Inc. and TherapeuticsMD, Inc. are both Drug Manufacturers Specialty & Generic companies. China Pharma Holdings, Inc. is the larger, with a market value of $22.8M against $19.8M — 1.2× the size. TherapeuticsMD, Inc. grew revenue faster over the last twelve months: 27.8% against −11.0%. TherapeuticsMD, Inc. has the higher net margin (−6.64% vs −114.3%) and the lower return on invested capital (−13.8% vs −7.23%). Across the 18 metrics below, TherapeuticsMD, Inc. leads on 11 and China Pharma Holdings, Inc. on 7.
Valuation
Profitability
| Metric | CPHI | TXMD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 11.76% | 100.00% | 53.51% |
| Operating margin | (111.84%) | (120.89%) | 0.00% |
| Net margin | (114.33%) | (6.64%) | (2.45%) |
| Free cash flow margin | (3.59%) | 94.71% | 0.00% |
| Return on equity | (20.99%) | (0.80%) | (0.80%) |
| Return on assets | (15.30%) | (0.57%) | (1.67%) |
| Return on invested capital | (7.23%) | (13.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack